Forte Biosciences, Inc. Income Statement

Income Statement Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2023 Dec2024
Revenue & cost
Revenue -0.29M0.05M0.04M18.04M0.04M
Gross Profit -0.29M0.05M0.04M18.04M0.04M
Operating items
Research & Development 19.17M27.22M29.11M51.08M45.30M
Selling, General & Administrative 3.83M4.52M8.56M12.81M16.25M
Other Operating Expenses -0.01M-1.19M
Operating Expenses 23.00M31.74M37.67M63.89M61.55M
Operating Income -22.95M-31.69M-37.63M-45.85M-61.51M
EBIT -22.95M-31.69M-37.63M-45.85M-61.51M
Non-operating items
Non Operating Investment Income -0.05M0.06M-0.03M0.01M0.03M
Interest & Investment Income 0.13M0.21M0.59M1.53M1.56M
Non Operating Income -0.10M-1.79M-1.30M
Net income details
EBT -23.17M-33.48M-38.93M-47.26M-63.52M
Tax Provisions 0.00M0.00M1.70M0.00M
Profit After Tax -23.06M-33.48M-38.93M-48.95M-63.52M
Income from Continuing Operations -23.17M-33.48M-38.93M-48.95M-63.52M
Consolidated Net Income -23.17M-33.48M-38.93M-48.95M-63.52M
Income towards Parent Company -23.17M-33.48M-38.93M-48.95M-63.52M
Net Income towards Common Stockholders -23.17M-33.48M-38.93M-48.95M-63.52M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 0.05M0.05M0.05M0.06M0.51M0.59M1.45M1.46M
EBITDA -23.11M-33.42M-38.96M-48.94M-63.48M